Reuters logo
BRIEF-Pharmstandart receives controlling stake in MasterPlazma
May 28, 2015 / 3:02 PM / 3 years ago

BRIEF-Pharmstandart receives controlling stake in MasterPlazma

May 28(Reuters) - Pharmstandart :

* Says has received 52 pct stake in MasterPlazma LLCSource text: bit.ly/1HygTUZ

Further company coverage:

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below